IL33 and myocardial infarction: In vitro and animal model studies have demonstrated that IL33/IL1RL1 isoform A signaling protects cardiomyocytes from apoptosis by suppressing Caspase 3 activity and promoting the expression of anti-apoptotic proteins in vitro and improves survival in experimental myocardial infarction (MI) animals [72].